172 related articles for article (PubMed ID: 32573972)
1. Monitoring CAR-T cell kinetics in clinical trials by multiparametric flow cytometry: Benefits and challenges.
Sarikonda G; Pahuja A; Kalfoglou C; Burns K; Nguyen K; Ch'en IL; Pollner R; Tangri S; Dakappagari N
Cytometry B Clin Cytom; 2021 Jan; 100(1):72-78. PubMed ID: 32573972
[TBL] [Abstract][Full Text] [Related]
2. Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses.
Sarikonda G; Mathieu M; Natalia M; Pahuja A; Xue Q; Pierog PL; Trampont PC; Decman V; Reynolds S; Hanafi LA; Sun YS; Eck S; Hedrick MN; Stewart JJ; Tangri S; Litwin V; Dakappagari N
Cytometry B Clin Cytom; 2021 Jan; 100(1):79-91. PubMed ID: 33373096
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry and pharmacokinetics.
Lang K; Matys K; Bennett P; Kakkanaiah VN
Bioanalysis; 2021 Nov; 13(21):1645-1651. PubMed ID: 34657485
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control.
Cai Y; Prochazkova M; Jiang C; Song HW; Jin J; Moses L; Gkitsas N; Somerville RP; Highfill SL; Panch S; Stroncek DF; Jin P
J Transl Med; 2021 Dec; 19(1):523. PubMed ID: 34952597
[TBL] [Abstract][Full Text] [Related]
5. New directions in chimeric antigen receptor T cell [CAR-T] therapy and related flow cytometry.
Maryamchik E; Gallagher KME; Preffer FI; Kadauke S; Maus MV
Cytometry B Clin Cytom; 2020 Jul; 98(4):299-327. PubMed ID: 32352629
[TBL] [Abstract][Full Text] [Related]
6. Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
de la Iglesia-San Sebastián I; Carbonell D; Bastos-Oreiro M; Pérez-Corral A; Bailén R; Chicano M; Muñiz P; Monsalvo S; Escudero-Fernández A; Oarbeascoa G; Fernández-Caldas P; Gómez-Centurión I; Pion M; Gayoso J; Anguita J; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Transplant Cell Ther; 2024 Mar; 30(3):306.e1-306.e12. PubMed ID: 38184148
[TBL] [Abstract][Full Text] [Related]
7. Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype.
Gargett T; Truong N; Ebert LM; Yu W; Brown MP
Cytotherapy; 2019 Jun; 21(6):593-602. PubMed ID: 30975603
[TBL] [Abstract][Full Text] [Related]
8. Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in Humans.
Liu C; Ayyar VS; Zheng X; Chen W; Zheng S; Mody H; Wang W; Heald D; Singh AP; Cao Y
Clin Pharmacol Ther; 2021 Mar; 109(3):716-727. PubMed ID: 33002189
[TBL] [Abstract][Full Text] [Related]
9. Bioanalytical Methods for Characterization of CAR-T Cellular Kinetics: Comparison of PCR Assays and Matrices.
Masilamani M; Jawa V; Dai Y; Das R; Park A; Lamba M; Wu F; Zheng X; Lu E; Gleason C; Mack T; Mora J; Surapaneni S
Clin Pharmacol Ther; 2023 Sep; 114(3):664-672. PubMed ID: 37422675
[TBL] [Abstract][Full Text] [Related]
10. Monitoring CAR T-cells using flow cytometry.
Demaret J; Varlet P; Trauet J; Beauvais D; Grossemy A; Hégo F; Yakoub-Agha I; Labalette M
Cytometry B Clin Cytom; 2021 Mar; 100(2):218-224. PubMed ID: 32841511
[TBL] [Abstract][Full Text] [Related]
11. Insights on Droplet Digital PCR-Based Cellular Kinetics and Biodistribution Assay Support for CAR-T Cell Therapy.
Sugimoto H; Chen S; Minembe JP; Chouitar J; He X; Wang H; Fang X; Qian MG
AAPS J; 2021 Mar; 23(2):36. PubMed ID: 33655393
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.
Adeel K; Fergusson NJ; Shorr R; Atkins H; Hay KA
Syst Rev; 2021 Jan; 10(1):35. PubMed ID: 33478595
[TBL] [Abstract][Full Text] [Related]
13. Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications.
Blache U; Weiss R; Boldt A; Kapinsky M; Blaudszun AR; Quaiser A; Pohl A; Miloud T; Burgaud M; Vucinic V; Platzbecker U; Sack U; Fricke S; Koehl U
Front Immunol; 2021; 12():658314. PubMed ID: 34012442
[TBL] [Abstract][Full Text] [Related]
14. Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.
Qi T; McGrath K; Ranganathan R; Dotti G; Cao Y
Adv Drug Deliv Rev; 2022 Sep; 188():114421. PubMed ID: 35809868
[TBL] [Abstract][Full Text] [Related]
15. Measuring Chimeric Antigen Receptor T Cells (CAR T Cells) Activation by Coupling Intracellular Cytokine Staining with Flow Cytometry.
Xu C; Yin Y
Methods Mol Biol; 2020; 2108():159-165. PubMed ID: 31939179
[TBL] [Abstract][Full Text] [Related]
16. Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling Approaches.
Chaudhury A; Zhu X; Chu L; Goliaei A; June CH; Kearns JD; Stein AM
J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S147-S159. PubMed ID: 33205434
[TBL] [Abstract][Full Text] [Related]
17. Prospects and challenges for use of CAR T cell therapies in solid tumors.
Ramakrishna S; Barsan V; Mackall C
Expert Opin Biol Ther; 2020 May; 20(5):503-516. PubMed ID: 32125191
[No Abstract] [Full Text] [Related]
18. Importance of CAR-T cell therapy monitoring using high-throughput assays.
Pratt CB; Alexander M
Drug Discov Today; 2022 Oct; 27(10):103310. PubMed ID: 35760281
[TBL] [Abstract][Full Text] [Related]
19. Advances and Challenges of CAR T Cells in Clinical Trials.
Holzinger A; Abken H
Recent Results Cancer Res; 2020; 214():93-128. PubMed ID: 31473850
[TBL] [Abstract][Full Text] [Related]
20. Generation of CAR-T Cells by Lentiviral Transduction.
Okuma A
Methods Mol Biol; 2021; 2312():3-14. PubMed ID: 34228281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
